Finland· FI-REL-REL513

Berenil Vet

A diminatseeni product containing diminazenum (lat.), registered in Finland by Aventis Pharma Deutschland GmbH.

ATC QP51AF01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedBerenil VetATCQP51AF01REGISTER NO.FI-REL-REL513PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Active substance
Diminazenum (lat.)
Manufacturer
Aventis Pharma Deutschland GmbH
Country
Finland (FI)
ATC code
QP51AF01
ATC class
Diminatseeni
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/db7d7ea3-f62f-48a2-9f97-7feec9215fd4
GET /v1/drugs/db7d7ea3-f62f-48a2-9f97-7feec9215fd4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektiokuiva-aine",
  "route": null,
  "ddd_unit": null,
  "strength": null,
  "atc_label": "Diminatseeni",
  "ma_number": "4715",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL513",
  "authorised_at": "1967-05-03"
}

See everything about diminazenum (lat.).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.